Mounjaro Research: How Dual GIP/GLP-1 Agonism Works
Tirzepatide (Mounjaro) is a 39-amino acid dual GIP/GLP-1 receptor agonist. Full mechanistic breakdown, SURPASS and SURMOUNT trial data, receptor biology, and comparison to retatrutide. Research purposes only.